View Older Stories View More Recent Stories

Aug 6, 2021 02:13PM Form SC 13G Mercury Ecommerce Acquis Filed by: Farallon Capital Partners, L.P.
Aug 5, 2021 08:02AM Cell and Gene Therapy Firms Grab Over $11 Billion So Far in 2021
Aug 3, 2021 05:30PM Form SC 13G Caribou Biosciences, Filed by: Farallon Capital Partners, L.P.
Aug 2, 2021 07:00AM Zentera Therapeutics Announces Closing of $75 Million Series B Financing
Aug 2, 2021 07:00AM Zentera Therapeutics Announces Closing of $75 Million Series B Financing
Jul 27, 2021 04:51PM Form SC 13G Imago BioSciences, Inc. Filed by: Farallon Capital Partners, L.P.
Jul 9, 2021 12:23PM Form D/A Farallon Capital F5 Inve
Jul 9, 2021 12:21PM Form D/A Farallon Capital F5 Inve
Jul 7, 2021 05:00PM Form SC 13G Shelter Acquisition Corp Filed by: Farallon Capital Partners, L.P.
Jun 30, 2021 04:05PM POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics Company
Jun 30, 2021 04:05PM POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics Company
Jun 24, 2021 05:07AM Senior Japanese lawmaker accuses Toshiba activists of short-termism
Jun 11, 2021 08:00AM Imago BioSciences’ Bomedemstat Demonstrates Continued Encouraging Clinical Activity in Phase 2 Data for Treatment of Essential Thrombocythemia and Myelofibrosis at EHA 2021 Virtual Congress
Jun 3, 2021 08:00AM Imago BioSciences Appoints Wan-Jen Hong, M.D., as Chief Medical Officer
Jun 1, 2021 01:33PM CP Group, Formerly Crocker Partners, Purchases Trio Of Prominent Atlanta Suburb Office Towers In Joint Venture With Farallon Capital Management
May 27, 2021 07:12AM GenapSys Announces $70 Million in Series D Equity Financing and Expansion of its Board of Directors
May 21, 2021 02:01PM Form SC 13D/A Playa Hotels & Resorts Filed by: FARALLON CAPITAL MANAGEMENT LLC
May 21, 2021 11:58AM Imago BioSciences to Present Updated Data from Phase 2 Studies of Bomedemstat for the Treatment of Essential Thrombocythemia and Myelofibrosis at 2021 European Hematology Association Virtual Congress
May 20, 2021 08:00AM BioTheryX Announces $92M Series E Financing to Accelerate Development of Targeted Protein Degradation Pipeline and Technology Platform in Oncology
May 17, 2021 09:01AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
May 17, 2021 09:01AM Form 13F-NT Farallon Capital Europe For: Mar 31
May 17, 2021 09:01AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Mar 31
May 14, 2021 12:39AM Toshiba unit hacked by DarkSide, conglomerate to undergo strategic review
May 10, 2021 06:02AM Form SC 13G Disruptive Acquisition Filed by: Farallon Capital Partners, L.P.
May 10, 2021 06:02AM Form SC 13G ARYA Sciences Acquisitio Filed by: Farallon Capital Partners, L.P.
May 10, 2021 06:02AM Form SC 13G Decarbonization Plus Filed by: Farallon Capital Partners, L.P.
May 10, 2021 06:02AM Form SC 13G Big Sky Growth Partners, Filed by: Farallon Capital Partners, L.P.
May 5, 2021 12:00AM NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology Platform
May 3, 2021 06:30AM Affinia Therapeutics Closes $110 Million Series B Financing
Apr 30, 2021 05:30PM Form SC 13G Khosla Ventures Acquisit Filed by: Farallon Capital Partners, L.P.
Apr 27, 2021 12:30PM Exscientia Announces Investment of up to $525M
Apr 25, 2021 10:00PM Toshiba must seek suitors, another big shareholder says, after CVC's $21 billion offer
Apr 16, 2021 05:33AM LUMICKS Raises $93 Million in Series D Financing
Apr 14, 2021 08:30AM Tango Therapeutics and BCTG Acquisition Corp. Announce Merger Agreement to Create Publicly Listed Precision Medicine Company Focused on the Next Generation of Targeted Cancer Therapies
Apr 14, 2021 03:50AM Exclusive: Toshiba CEO faced board ouster before $20 billion buyout offer - sources
Apr 13, 2021 07:00AM Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors
Apr 12, 2021 11:08PM Toshiba CEO to step down as board meets Wednesday to consider his future: source
Apr 12, 2021 07:00AM Farallon Comments on Privatization Proposal to Toshiba by CVC
Apr 12, 2021 05:48AM Toshiba faces investor call to seek alternatives to CVC bid
Apr 7, 2021 08:07AM Better Therapeutics to Become Publicly Traded via Merger with Mountain Crest Acquisition Corp. II (MCAD)
Apr 7, 2021 08:02AM Better Therapeutics to Become Publicly Traded Prescription Digital Therapeutics Company via Merger with Mountain Crest Acquisition Corp. II
Mar 31, 2021 05:06PM Form SC 13G Khosla Ventures Acquisit Filed by: FARALLON CAPITAL MANAGEMENT LLC
Mar 29, 2021 07:01AM SomaLogic to Combine with SPAC CM Life Sciences II (CMIIU)
Mar 29, 2021 07:00AM SomaLogic, Leading AI-Data Driven Proteomics Platform for Advanced Research and Clinical Applications, to Combine with CM Life Sciences II, to Drive Growth and Expand Technology Platform
Mar 25, 2021 06:02AM Form SC 13G Longboard Pharmaceutical Filed by: FARALLON CAPITAL MANAGEMENT LLC
Mar 24, 2021 03:38AM Activist-backed proposal for Toshiba probe received 58% of shareholder votes
Mar 17, 2021 10:25PM Shareholder Votes at Toshiba EGM Represent Clear Mandate for Greater Transparency and Accountability
Mar 17, 2021 10:18PM Toshiba shareholders vote for probe in landmark win for Japan corporate governance
Mar 16, 2021 08:00AM Ventyx Biosciences Doses First Subject in a Phase 1 Trial of VTX-958, a Selective Allosteric TYK2 Inhibitor for Autoimmune Diseases
Mar 16, 2021 07:46AM Activist Toshiba shareholders tipped to win crucial vote on independent probe this week
View More Recent Stories View Older Stories